IP Library Granted Patent US 9,011,897
Granted Patent B2
US 9,011,897 · App. 13/779,637 · Granted Apr 21, 2015

Catheter lock solution comprising citrate and a paraben

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,011,897
App. No.
13/779,637
Granted
Apr 21, 2015
Kind
B2
Abstract

This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue.

Claims (18)

1. An aqueous antimicrobial composition comprising about 1.5 to about 47% citrate and about 0.005 to about 0.6% (g/100 ml) or the solubility limit of a paraben dispersed or dissolved therein.

2. The aqueous antimicrobial composition of claim 1 , wherein the paraben is methyl paraben, propyl paraben, or a combination thereof.

3. The aqueous antimicrobial composition of claim 1 , wherein the composition comprises about 0.005 to about 0.5 percent (g/100 ml) methyl paraben.

4. The aqueous antimicrobial composition of claim 1 , wherein the composition comprises about 0.005 to about 0.5 percent (g/100 ml) propyl paraben.

5. The aqueous antimicrobial composition of claim 1 , wherein the composition comprises about 0.05 to about 0.5 percent (g/100 ml) methyl paraben, and about 0.005 to about 0.5 percent (g/100 ml) propyl paraben.

6. The aqueous antimicrobial composition of claim 1 , wherein the concentration of citrate in the solution is at least as high as the calcium concentration in a patient's blood.

7. The aqueous antimicrobial composition of claim 1 , wherein the citrate has a concentration of from about 1.5 to about 15% by weight.

8. The aqueous antimicrobial composition of claim 1 , wherein the citrate is trisodium citrate dihydrate.

9. The aqueous antimicrobial composition of claim 1 , wherein the pH of the solution is from about 4 to about 8.

10. The aqueous antimicrobial composition of claim 1 , wherein the relative density of the solution is from about 1.000 to about 1.300 g/ml.

11. The aqueous antimicrobial composition of claim 1 , wherein the solution further comprises a viscosifying agent.

12. The aqueous antimicrobial composition of claim 1 , further comprising alcohol.

13. The aqueous antimicrobial composition of claim 1 , wherein the paraben has a concentration of about 0.1 percent to about 0.3 percent.

14. The aqueous antimicrobial composition of claim 1 comprising about 0.01-1 M citrate.

15. The aqueous antimicrobial composition of claim 14 , wherein the paraben has a concentration of about 0.1% to about 0.3% by weight.

16. A method of locking a catheter comprising introducing an aqueous antimicrobial composition of claim 1 into a lumen of the catheter.

17. The aqueous antimicrobial composition of claim 1 , wherein the paraben has a concentration of from about 0.005 to about 0.6% percent (g/100 ml).

18. The aqueous antimicrobial composition of claim 14 , wherein the paraben has a concentration of from about 0.005 to about 0.6% percent (g/100 ml).

Assignments (2)
SECURITY INTEREST Recorded Dec 30, 2021
From: ZUREX PHARMA, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 058504/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2018
From: TRUITT, ROBERT B.
To: ZUREX PHARMA, INC.
Reel/Frame 044955/0298 →